| Common Stock, Shares Authorized |
700M |
shares |
|
Q1 2023 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0.04 |
USD/shares |
0% |
Q4 2023 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.06M |
USD |
+5147% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
7.12M |
USD |
+59.8% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
576K |
USD |
+30.3% |
Q2 2023 |
FY 2023 |
| Operating Lease, Liability |
207K |
USD |
+1.68% |
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
207K |
USD |
0% |
Q2 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
39.6K |
USD |
0% |
Q4 2023 |
Q2 2024 |
| Operating Lease, Liability, Current |
207K |
USD |
+6.16% |
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
207K |
USD |
+4.35% |
Q2 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
38 |
USD |
-98.9% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
41.9K |
USD |
-98.9% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
228M |
USD |
+12.3% |
Q4 2023 |
Q2 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
700K |
USD |
0% |
Q2 2025 |
FY 2025 |